Johnson Dana M, Ramaswamy Sruthi, Gomperts Rebecca, Aiken Abigail R A
Population Health Sciences, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA
McKetta Department of Chemical Engineering, The University of Texas at Austin, Austin, Texas, USA.
BMJ Sex Reprod Health. 2024 Dec 31. doi: 10.1136/bmjsrh-2024-202580.
Advance provision of medication abortion, or the prescription of mifepristone and misoprostol before pregnancy occurs, is an unexplored care model aimed at expanding abortion access. We examine motivations for obtaining advance provision from the online telemedicine service, Aid Access, which supports people in the United States.
Between May and November 2023, we conducted semi-structured, in-depth interviews with 39 people who obtained advance provision between January 2022 and April 2023. Interviews were transcribed and we conducted a thematic analysis to assess individual motivations.
Participants were motivated to obtain medications because of the ) draft opinion leak and eventual decision. Participants expressed concerns about access to abortion under current and future abortion restrictions. Concerns about restrictions prompted people to make a backup plan for themselves and loved ones, and participants compared advance provision to other emergency medications and practices. Some participants were motivated to have medications on hand because pregnancy would be either unsafe or difficult. Others were trying to become pregnant, but because of their health histories they were cognisant of the health risks of a desired pregnancy. Overall, participants were motivated to take back control of their reproductive autonomy in the face of inevitable abortion bans.
The need for autonomy, resistance and reassurance were woven throughout participant's motivations for obtaining advance provision. The decision acted as a catalyst for action to take back reproductive autonomy and prepare for a lack of access to abortion care.
提前提供药物流产，即在怀孕前开具米非司酮和米索前列醇的处方，是一种旨在扩大堕胎途径的未被探索的护理模式。我们研究了从支持美国民众的在线远程医疗服务“援助通道”获取提前提供药物流产服务的动机。
2023年5月至11月期间，我们对39名在2022年1月至2023年4月期间获得提前提供药物流产服务的人进行了半结构化的深入访谈。访谈内容被转录，我们进行了主题分析以评估个人动机。
参与者因（此处原文缺失部分内容）意见草案泄露及最终决定而有动力获取药物。参与者表达了对当前和未来堕胎限制下堕胎途径的担忧。对限制的担忧促使人们为自己和所爱的人制定备用计划，参与者将提前提供药物流产服务与其他急救药物及做法进行了比较。一些参与者因怀孕不安全或困难而有动力准备好药物。其他人试图怀孕，但由于他们的健康史，他们意识到期望怀孕存在健康风险。总体而言，面对不可避免的堕胎禁令，参与者有动力夺回对其生殖自主权的控制。
对自主权、反抗和安心的需求贯穿于参与者获取提前提供药物流产服务的动机之中。（此处原文缺失部分内容）决定成为了夺回生殖自主权并为无法获得堕胎护理做准备的行动催化剂。
